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Alexithymia is of great interest as an outcome predictor of recovery from anorexia nervosa,
since it may interfere with both treatment compliance and patients’ ability to benefit from
the adopted interventions. For this reason, in the last years new treatment approaches
targeting emotion identification, expression, and regulation have been applied and tested.
Using the PRISMA methodology, we performed a scoping review of the literature about
treatment outcome in anorexia nervosa, in terms of changes in alexithymia as assessed by
its most commonly used self-report measure, the Toronto Alexithymia Scale (TAS). The
Medline and Scopus databases were searched, and articles were included if matching the
following criteria: dealing with patients affected by anorexia nervosa, without limits of age;
involving the application of any kind of targeted therapy or treatment; assessing
alexithymia and the effect of a treatment intervention on alexithymia, using the TAS. Ten
studies were eventually included; overall, according to the selected studies, alexithymia
levels often remain high even after specific treatment. Further research aimed at a deeper
understanding of the actual impact of alexithymia on the outcome of anorexia, as well as
exploring alternative treatment strategies for alexithymia in eating disorders (EDs),
are warranted.
Keywords: alexithymia, anorexia nervosa, systematic review, PRISMA, treatment, outcomeINTRODUCTION
Alexithymia is defined as a difficulty and inability in identifying and describing feelings and
emotions (1): alexithymic individuals usually show a paucity of words to describe their affective
status, and find it difficult distinguishing feelings from physical sensations. Furthermore,
alexithymia is characterized by a diminution of fantasy and a concrete and externally-oriented
thinking style (2). It is likely a stable personality trait reflecting an impairment of emotion regulation
(3, 4), rather than a state-dependent phenomenon linked to depression or to clinical status (5, 6).
Impaired emotional functioning and alexithymic traits are core features of anorexia nervosa,
both in the adolescent and adult population (7–15): they seem to be independent from depressive
symptoms and eating disorder severity (16–18) and express themselves as a concrete, reality-based
cognitive style and a poor inner emotional and fantasy life.g February 2020 | Volume 10 | Article 9911
Gramaglia et al. Alexithymia, Treatment Outcome in AnorexiaA “cognitive-affective” division (19) has been suggested to
describe the experience of patients with eating disorders (EDs)
when trying to translate their thoughts at a cognitive level into
what is felt from an emotional standpoint. The emotional
difficulties of individuals with anorexia nervosa (AN) may not
depend on a primary impairment in emotion recognition, but
rather on inhibition or avoidance occurring after a proper
acknowledgment of others’ emotions (20), possibly due to
patients’ feelings of being overwhelmed by over-control and
anxious worry (21). Alexithymic traits in AN may cause
patients avoiding or regulating the experience of emotions,
especially those perceived as negative or disruptive (22),
with inappropriate behaviors (restriction, binges, purges,
body checking behaviors) (23), leading to a gap between the
inner experience of negative affect and its expression (13).
Actually, also in a non-clinical sample of undergraduate
women, alexithymic individuals, compared to non-alexithymic
ones, had more body checking behaviors, greater body
dissatisfaction, and higher potential risk for EDs (24).
Implications at the social level of alexithymia and emotional
difficulties (such as emotional avoidance and poor regulation),
include low social emotional intelligence (25), problems with
intimacy, attachment and social communication or interactions
(26–29), and social anhedonia (30, 31).
Moreover, alexithymia and emotion regulation difficulties
have been shown to have an impact on the course and
maintenance of anorexia (12, 15, 32, 33), and on treatment
outcome and recovery (34, 35). Actually, the lack of insight and
the externally-oriented thinking style typical of alexithymia may
interfere with treatment compliance and with patients’ ability to
benefit from interventions, especially psychotherapy ones (36).
According to these clinical observations, in the last years the
need to explore new treatment approaches targeting emotion
identification, expression and regulation has emerged, with the
aim of fostering the process of recovery, enhancing quality of life
(27) and improving long-term outcomes in the ED population
(32). Another issue which should not be overlooked is that,
notwithstanding patients’ primary psychiatric diagnosis,
increasing evidence suggests that alexithymia may play a role
as risk factor for suicide, often mediated by depressive symptoms
(37, 38). Biological correlates of the relationship between
alexithymia and suicidal behaviors have been suggested,
including for instance homocysteine dysregulation (39). This
evidence further supports the importance to screen for
alexithymia in the everyday clinical practice with psychiatric
patients, including those suffering from EDs (40). The aim of the
current scoping review was to assess treatment outcome in AN in
terms of changes in alexithymia as assessed by its most
commonly used self-report measure, the Toronto Alexithymia
Scale (TAS).METHODS
A scoping review was conducted in accordance with the
Preferred Reporting Items for Systematic Reviews and Meta-Frontiers in Psychiatry | www.frontiersin.org 2Analyses [PRISMA Statement; (41)]. The Medline and Scopus
databases were searched on August 30th, 2019, and on September
2nd, 2019. For Medline, the following keywords were used:
[(anorexia nervosa) AND (Toronto Alexithymia Scale)] AND
((therapy) OR treatment). Scopus was searched with the
following research string: [ALL (“anorexia nervosa”) AND ALL
(Toronto AND Alexithymia AND Scale) AND ALL (treatment
OR therapy)] AND [LIMIT-TO (DOCTYPE, “ar”)] AND
[LIMIT-TO (LANGUAGE, “English”)].
Two independent reviewers (EG and CG) assessed the articles
identified by the above described key words. To be included in
the review, studies had to: (a) be clinical trials dealing with
patients affected by AN, without limits of age; (b) involve the
application of any kind of targeted therapy or treatment; (c)
assess alexithymia and the effect of a treatment intervention on
alexithymia, using the TAS. Only articles in English were
considered eligible. The presence of a control group was not
considered an inclusion criterion. Studies which did not match
the inclusion criteria described above were excluded. Possible
disagreement between reviewers was resolved by joint discussion
with a third review author (PZ). Quality of studies was assessed
with the Newcastle Ottawa Scale (NOS) (42) by the reviewers
who assessed the articles (EG and CG).
Data extracted from the selected studies were recorded in a
datasheet using a standardized coding form, including the
following categorical and numerical variables: general
information about the study (author/s, year of publication,
title, journal title, volume, pages, country, study type), sample
features (sex, age, BMI, years of illness, diagnosis, treatment;
medical and psychiatric comorbidities; sample size, number in
experimental group, number in control group, lost at follow-up),
setting (inpatient, outpatient…), type of intervention (group,
individual, setting…), questionnaires used, study outcome
(primary or secondary), main study results.RESULTS
Selection Process
As described in the PRISMA flow diagram (Figure 1) (43), the
initial search identified 384 titles (17 from Medline, 367 from
Scopus); after removing 13 duplicates, titles were screened first,
and those clearly not in line with the purpose of the review were
excluded (N = 276). Then abstracts were assessed, leading to the
exclusion of 71 records, and last full texts were read, eventually
leading to the inclusion of 10 papers (2, 15, 32, 44–50) in the
qualitative synthesis.Quality Assessment
The NOS scores for the included studies ranged from 1 to 6, with
a mean score of 3.9 ± 1.59 (SD).Description of Study Features
The main features of the selected studies are shown in Table 1.February 2020 | Volume 10 | Article 991
Gramaglia et al. Alexithymia, Treatment Outcome in AnorexiaDetails about treatment were reported for the approaches
described below; in the other cases, no specific details were
described apart from those reported in Table 1.
CREST (15, 51–53) is a low-intensity individual manualized
treatment for inpatients with severe AN, based on the cognitive
interpersonal model. It targets rigid and detail-focused thinking
styles but also has a strong emphasis on emotion recognition
skills and emotion management and expression. The aim is to
help patients learn about the function of emotions (including the
communication of needs to self and others), and to improve skills
in emotion labeling, identification, and tolerance in self
and others.
Lunbad and coworkers (47) described in detail the group
psycho-pedagogic method applied at the Anorexia & Bulimia
Clinic for Adults at the Sahlgrenska University Hospital.Frontiers in Psychiatry | www.frontiersin.org 3According to the theoretical premise that alexithymia implies
an inability to handle negative feelings, eventually requiring a
“protective” or “blocking” ingredient (ED symptoms). The aim
of the method is to help patients cope with negative feelings.
Group Cognitive-Behavior Therapy (G-CBT) as described
by Ohmann et al. (45) includes the following modules:
therapeutic motivation, psycho-education, individual problem
analysis, (teaching of) problem solving strategies, soft and
communication skills, hedonistic training, elements of
awareness, body and schema psychotherapy (54). While the
primary therapeutic goals are weight gain and improvement of
eating behavior, the secondary goal is improved emotional
functioning, including alexithymia measures.
Becker-Stoll and Gerlinghoff (48) described a three-phase
treatment program (4-week outpatient motivation phase, 4-monthFIGURE 1 | PRISMA 2009 Flow Diagram.February 2020 | Volume 10 | Article 991
TABLE 1 | Main features of the clinical studies included in the review.
Main results NOS
e relationship
lexithyimic
nd treatment
a naturalistic
e study.
Global improvement of
alexithymia and depression.
TAS scores not influenced by
antidepressants, psychotherapy,
or both.
Patients received different
treatments (number, type)
according to their alexithymic
profile.
Patients with high levels of
alexithymia: more treatments
and more antidepressants.
Patients who became
alexithymic during follow-up:
more often re-hospitalized;
fewer psychotherapies.
4
SAS and TAS
: perceived
e to change”
y to change”;
Decrease of anhedonia (RSAS)
and alexithymia (TAS) after
CREST.
Increase of perceived “ability to
change” and of BMI.
3
of CREST-YP.
e of YP
REST-YP.
functioning pre-
intervention.
Themes reported by IP:
Exploring emotions; Emotions
and ED; Homework,
Suggestions for improvement.
Quantitative results only partially
supporting qualitative ones: no
significant change in ERQ-CA,
RSAS, TAS, and motivational
ruler scores.
CREST-YP is a suitable
intervention for YP with AN.
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Sample features Setting Intervention assessed Assessment Outcome
Speranza
et al. (2)
N = 102 with complete
assessment (initial sample
N = 144; directly interviewed
N = 109)
Gender 100% females
Age, mean 21.5 ( ± 5)
Diagnosis AN (N = 63) or BN
(N = 39) (DSM-IV)
BMI n.s.
Illness duration, mean 4.3
( ± 4.8)
Comorbidities, anxiety and
depressive disorders,
substance-related disorders
diagnosed with Mini
International Neuropsychiatric
Interview (MINI).
Multicenter research
project involving
academic psychiatric
hospitals.
Treatments could include (1) pharmacotherapy, any
kind, for at least 3 months; (2) Psychotherapy, any
kind, for at least 6 months; (3) Hospitalization, either full
or partial; (4) Pharmacotherapy + psychotherapy.
Assessment at
baseline and 3-
year follow-up
with:
clinical interview
BDI-13
CGI
MINI
MMPI-2 (Negative
Treatment
Indicators scale)
TAS (cutoff ≥56)
Explore th
between a
features a
choices in
prospectiv
Tchanturia
et al. (15)
N = 33 who attended all 10
sessions and completed both
pre- and post-intervention
assessments (63% of the
sample who completed
baseline measures)
Gender n.s.
Age, mean 24.5 ( ± 8.2)
Diagnosis AN (n.s.)
BMI, mean 15.1 ( ± 1.95)
Illness duration, mean 8
( ± 7.2)
Comorbidities (n.s.)
Inpatient, South
London and Maudsley
National Adult EDs
Service.
CREST: manualized 10-session intervention
addressing emotion processing, in individual format.
Includes psycho-education, experiential exercises,
homework tasks.
RSAS
TAS
Motivational ruler
exploring
importance to
change and
perceived ability
to change
Primary: R
scores.
Secondar
“importan
and “abilit
BMI
Giombini et
al. (32)
N = 32 who completed the
group cycle
Gender 87.5% females
Age, mean 14.03 ( ± 1.75)
Diagnosis AN (DSM-5 criteria)
Weight for height %, mean
75.68 ( ± 6.44)
Illness duration n.s.
28.1% comorbidities.
Inpatient child and
adolescent EDs unit
offering multi-
disciplinary treatment
(individual, family, and
group therapy).
CREST-YP: manualized 5-session intervention, weekly,
in group format. Includes psychoeducation, experiential
exercise, homework.
Semi-structured
qualitative
interview created
ad hoc.
SQ
ERQ-CA
RSAS
TAS
Motivational ruler
assessing self-
reported
importance to
change and
ability to change.
Data collected at
the beginning
Suitability
Experienc
receiving
Emotiona
and post-y
c
C
l
TABLE 1 | Continued
Main results NOS
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In the group of AN patients,
decrease of DIF and EOT from
the starvation to the weight
restoration phase. No change in
DDF. Overall improvement in
alexithymia.
6
nges of the
ogical
ing the
BT and 1-
.
whether G-
e for the
dolescent
er
factors
ate the
disorder.
atients with
handling of
ld have a
nt outcome.
Severe and multiple emotional
deficits, difficulties of emotional
control, problems in self-
confidence and self-efficacy in
AN.
Especially in patients with poor
outcome: problems in
intrafamilial communication and
expression of emotions.
Alexithymia and SOC were
disturbed and resistant to
change in all patients.
Problems in handling, detecting,
and expressing emotions are
involved in promoting and
maintaining anorexic behavior,
and are resistant to change,
especially in the patients with
poor outcome.
4
e efficacy of
gram.
e rate of
d
roneness in
efore and
t).
Treatment was associated with
a significant improvement
in eating symptoms (50%
decrease in the EAT-26 and
EDI- 2 scores), but not with a
significant decrease on the DES
and TAS-26 scores.
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and at the end of
the cycle.
Beadle et
al. (44)
N = 20 AN patients tested
both during starvation and
after weight restoration (out of
N = 26 tested at baseline);
compared to 16 age-matched
healthy women at comparable
timepoints.
Gender 100% female
Age in the AN sample, mean
24.4
( ± 5.5).
Diagnosis AN (ANP or ANR)
BMI: mean 15.7.
Weight restoration defined as a
BMI of at least 18.5 (in the 20
patients sample, mean BMI at
time 2, 20.16 ( ± 1.24).
Illness duration = n.s.
Comorbidities n.s.
Inpatient or outpatient
day program following
hospitalization.
Inpatient eating disorder program: daily cognitive
behavioral therapy, group and individual therapy,
supervised eating, occupational and recreational
therapy, physician supervision.
EAT
EDI-3
YBC-EDS
HDRS
HARS
WAIS-IV CPT II
Stroop Color and
Word Test
WCST
TAS-20
IRI MMPI-2 (37
items).
Differences (d
cognitive, clin
personality ch
between part
AN and healt
Differences b
the starvation
restoration ph
the AN group
Examination
relationships
alexithymia, e
empathy, and
regulation, co
depression a
when relevan
Ohmann et
al. (45)
N = 29
Gender 100% female
Age, mean
14.3 (range 13–17)
Diagnosis AN (ICD-10
Criteria): N = 22 ANR; N = 7
ANB
BMI, mean 15 (range 13–17)
Illness duration, mean 7.2
months (range 2–18).
Comorbidity in N = 23 cases
N = 5 patients (17%) treated
with antidepressants.
N = 3 had previous
psychotherapy.
Eating Disorder
Outpatient Clinic,
Department of Child
and Adolescent
Psychiatry,
Medical University of
Vienna (recruitment
between
May and September
2003–2006).
A maximum of 40 weekly sessions (90 minutes each)
of Multimodal G-CBT program, including 9 modules:
therapeutic motivation, psycho-education, individual
problem analysis, (teaching of) problem solving
strategies, soft and communication skills, hedonistic
training, elements of awareness, body and schema
psychotherapy.
Family sessions once monthly.
YSR (baseline
and 9-months
after)
At baseline and
3-6-9 and 12-
months follow-
up: EDE
BDI
FBA
ASW
MUM
EV-H
EV-A
MUM-SOC
SPS
SIAS
BIKS
TAS
To assess ch
psychopatho
measures du
course of G-C
year follow-up
To investigate
CBT is effecti
treatment of
AN and whet
emotional risk
might compli
course of the
Hypothesis: p
less disturbed
emotions wo
better treatm
Iancu et al.
(46)
N = 30 soldiers
with ED
Gender 90% female.
Age, mean 19.5 (range 18–21).
Diagnosis N = 10 AN (33%);
N = 15 BN (50%); N = 5
EDNOS (17%) (DSM-IV).
Eating Disorder Clinic
at the Zeriffin Mental
Health Clinic, Israel
Defense Forces
(2001–2003).
Weekly group meetings (90 minutes)
6 months (lead by a social worker with a social worker
and a dietitian as cotherapists)
Meetings included: psychoeducation; cognitive
behavioral therapy combined with a dynamic
approach.
Assessment
before and after
the intervention
with:
EDI-2
EAT-26
To examine t
treatment pro
To evaluate t
alexithymia a
dissociation p
the sample (b
after treatmeni
i
h
e
o
b
m
n
t
a
l
r
v
a
h
c
u
e
h
h
n
TABLE 1 | Continued
Main results NOS
hanges after Significant reduction (pre- to
post- intervention) of alexithymia
(TAS).
Alexithymia negatively correlated
with education; no correlation
with illness duration, weight loss,
depression, general
psychoneurotic pathology.
1
onth
gram has an
lexithymia in
ether
edicts
come in the
.
High levels of alexithymia in AN
and BN patients, without any
difference in TAS scores
between AN and BN.
TAS scores decreased from
pre- to post- treatment as well
as EDI ones. Baseline scores for
alexithymia did not predict post-
treatment outcome.
4
ity.
disorder
sychological
decision
Full mental capacity group: mild
AN at follow-up; improvement in
alexithymia score (below the
cutoff of 52 for possible
alexithymia); improvement of
BMI.
Diminished mental capacity
group: moderately ill category
(DSM-5) at follow-up; no
improvement of alexithymia;
improvement of BMI; higher
likelihood of inpatient treatment.
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BMI n.s.
Illness duration n.s.
Comorbidities, No Axis I
comorbidity
90% had a personality disorder
(mostly borderline or
narcissistic) according to the
SCID-II questionnaire
TAS-26
DES
Lundbad et
al. (47)
N = 30
Gender 100% female
Age range 25–40.
Diagnosis AN and/or BN (type
of eating disorder described by
patients
and EDI-2 questionnaire)
BMI n.s.
Illness duration, > 5 years
Comorbidities, n.s.
Referred from the
Department of
General Psychiatry,
Sahlgrenska University
Hospital (Anorexia and
Bulimia Clinic for
Adults), Sweden.
Psycho-pedagogic method facilitating the ability of
patients to cope with negative feelings: 8 weekly
written and oral sessions teaching and coaching about
emotional/affective status, in a group format.
TAS TAS scores c
intervention.
Becker-
Stoll and
Gerlinghoff,
(48)
N = 47 (N = 18 AN; N = 25
BN; N = 4 EDNOS)
Gender 100% female
Age, mean 21.7 ( ± 3.4; range
16–30).
Diagnosis AN and BN (DSM-IV
criteria).
BMI, mean in AN 16.2 ( ± 1.5);
mean in BN 22.8 ( ± 6.1)
Illness duration n.s.
Comorbidities n.s.
Day Hospital at the
TCE, Max Planck
Institute of Psychiatry,
Munich (2001).
TCE: three-phase treatment program consisting of a
4-week outpatient motivation phase, a 4-month day
hospital phase, and a 4-month outpatient follow-up
treatment phase. Group psychotherapy includes
cognitive-behavioral, psycho-educational and
interpersonal interventions.
Exercises to support body acceptance, including
video-confrontation, relaxation techniques, and dance
therapy.
Pre- and post-
treatment
assessment with:
EDI (total score)
TAS-20
To determine
whether a 4-
treatment pro
influence on a
ED patients.
To assess wh
alexithymia p
treatment ou
ED populatio
Elzakkers
et al. (49)
N = 70 (N = 56 assessed at 1-
year follow-up; N = 50 at 2-
year follow-up)
Gender 100% female
Age, mean 27.3 ( ± 9.7)
Diagnosis, % ANR/ANP 49/51
(Severity of eating disorder
symptoms was rated with the
EDEQ
BMI, mean 15.5 ( ± 1.9)
Illness duration, mean 8.6
( ± 8.1)
Comorbidities n.s.
National specialist
center for the
treatment of eating
disorders.
Treatment including individual and group therapies,
psychomotor therapy, rehabilitation on and outpatient,
day-hospital or inpatient basis.
Baseline, 1- and
2-year follow-up.
BMI
BDI-II
EDEQ
IGT
MacCAT-T
STAI
TAS
Full remission
defined as
having: BMI
range 18.5–25;
resumed menses;
no disabling
anorectic
conditions.
Partial remission
Mental capac
Relation of th
course with p
variables and
making.m
r
t
n
e
TABLE 1 | Continued
Assessment Outcome Main results NOS
defined as
satisfying 2 out of
the 3 criteria
described above.
oup formats
kly sessions,
nd experiential
0 minutes.
at any time.
Assessment
before and after
individual and
group
interventions
with:
RSAS
TAS
Motivational ruler
(ability to change,
importance to
change)
AQ-10
BMI
Effectiveness of CREST
interventions.
TAS and RSAS scores.
ASD symptoms.
Individual CREST: improvement
in patients’ alexithymia; increase
in motivation; no impact on
social anhedonia; significant
effect of ASD symptoms on
RSAS and TAS scores.
Group CREST: increase in
motivation; no impact on social
anhedonia and alexithymia;
significant effect of ASD
symptoms on TAS scores.
2
estionnaire; ASD, Autism Spectrum Disorder; ASW, Assessment of Self-Efficacy; BDI, Depression Inventory; BIKS, Beck
erapy; CGI, Clinical Global Impression; CPT II, Conners' Continuous Performance Test-II; CREST, Cognitive Remediation
issociation Experience Scale; DDF, Difficult Describing Feelings; DIF, Difficult Identifyng Feelings; DSM, Diagnostic and
e; EDI-3, Eating Disorder Inventory; EOT, Externally Oriented Thinking; ERQ-CA, Emotional Regulation Questionnaire for
ilton Depression Rating Scale; IGT, Iowa Gambling Task; IRI, Interpersonal Reactivity Index; MacCAT-T, MacArthur
ltiphasic Personality Inventory; MUM, EV-H, EV-A, Marburg Scale of Euthymic Disorder; MUM-SOC, Marburg Sense of
SPS, social phobia scale; SQ, Satisfaction Questionnaire; STAI, Spielberger State Trait Anxiety Inventory; TAS, Toronto
, Youth Self Report; YBC-EDS, Yale-Brown-Cornell Eating Disorder Scale.
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Adamson
et al. (50)
Individual CREST, N = 66
Gender 100% female
Age, mean 25.8 (range 18–53)
Diagnosis AN, (DSM-5)
BMI, mean 14.8 ( ± 1.3)
Illness duration, mean 8
( ± 8.5)
Score above the AQ10 cutoff
32%
Group CREST, N = 62
Gender 100% female
Age, mean 25.5 (range 18–63)
Diagnosis AN, DSM-5
BMI, mean 14.8 ± 1.4)
Illness duration, mean 7.6
( ± 8.3)
Score above the AQ10 cutoff
34%
Comorbidities, n.s.
Inpatient. CREST in individual (N = 66) and g
(N = 62).
Individual format: manualized 8 wee
40–45 minutes. Psychoeducation a
exercises.
Group format: 5 weekly sessions, 6
Optional, participants can drop out
AN, Anorexia Nervosa; ANP, Anorexia Nervosa Purging Type; ANR, Anorexia Nervosa Restrictive Type; AQ, Autism Q
Inventory of Cognitive Schemata; BMI, Body Mass Index; BN, Bulimia Nervosa; G-CBT, Cognitive Behavioral Group T
and Emotion Skills Training; CREST-YP, Cognitive Remediation and Emotion Skills Training—Young People; DES, D
Statistical Manual for Mental Disorders; EAT, Eating Attitudes Test; EDEQ, Eating Disorder Examination Questionnai
Children and Adolescents; FBA, General Family Questionnaire; HARS, Hamilton Anxiety Rating Scale; HDRS, Ha
Competence Assessment Tool-Treatment; MINI, Mini International Neuropsychiatric Interview; MMPI, Minnesota Mu
Coherence Scale; n.s., not specified; RSAS, Revised Social Anhedonia Scale; SIAS, Social Interaction Anxiety Scale
Alexithymia Scale; TCE, Treatment Center for Eating Disorders; WCST, Wisconsin Card Sorting Test Version 4; YSRr
u
h
r
m
;
Gramaglia et al. Alexithymia, Treatment Outcome in Anorexiaday hospital phase, 4-monthoutpatient follow-up), including group
cognitive-behavioral psychotherapy, psycho-educational and
interpersonalinterventions.
Iancu et al. (46) adopted a group therapy combining a
cognitive-behavioral and a dynamic approach; with more
detail, the latter proposes a dynamic understanding of ED
symptoms as an externalization of an unsolved conflict.DISCUSSION
Overall, according to the studies included in the review,
alexithymia levels sometimes remain high even after
specific treatment, while changes and improvements may occur
in other outcome indicators (e.g. body mass index, eating
symptomatology, motivation).
Some studies clearly failed to find a positive impact of
treatment on alexithymia as assessed with the TAS (32, 45, 46).
On the other hand, others supported an improvement of
alexithymia after treatment (2, 15, 44, 47, 48), which was
represented by CREST (15), a mixed approach including
different types of treatment (2, 44), a 4-month day hospital
treatment (48), and a psycho-pedagogic intervention (47),
respectively (see Table 1 for more details). Last, mixed findings
have been reported by a couple of studies. An improvement of
TAS scores was reported in a subgroup of patients with AN (full
mental capacity) but not in another (diminished mental
capacity) (49). Furthermore, CREST was described as effective
in reducing alexithymia when offered in an individual format,
but not in a group one (50).
General Information
All studies but one (2) involved a single center. Most studies were
performed in a hospital setting, on inpatients; only four studies
included outpatients (44, 45, 48, 49). Samples size ranged from
29 to 168 patients. One study (44) included also a control group,
composed by 16 age-matched healthy women.
Participants’ Features
The studies included in this review involved patients with an age
range from 12 to 63 years old; two studies (32, 45) were
specifically focused on an adolescent population. Most studies
included only female patients, while two (32, 46) assessed both
genders. From a clinical standpoint, four of the 10 studies
selected for this review involved patients with different types of
EDs: AN-R; AN-P; BN; EDNOS (2, 46–48), while six studies
included only AN patients (15, 32, 44, 45, 49, 50). More
specifically, diagnosis was made according to DSM-IV criteria
in three studies (2, 46, 48), to ICD-10 criteria in one study (45)
and to DSM-5 criteria in another one (50). In 2 studies (47, 49)
the type of ED was assessed using different questionnaires
(respectively EDI-2 and EDEQ). The remaining five studies did
not specify the diagnostic criteria used (15, 32, 44, 47, 49).
Patients’ BMI ranged from 13 to 21.4; illness duration, when
specified, ranged from 1 month to more than 5 years.
Comorbidities were specified in four studies (2, 32, 45, 46).Frontiers in Psychiatry | www.frontiersin.org 8Intervention Features
All studies but two (2, 47) applied cognitive interventions (15, 32,
44–46, 48, 50). More specifically, patients enrolled in three
studies (15, 32, 50) were treated with CREST, in a group
format; furthermore, Adamson et al. (50) used CREST in an
individual therapy setting as well. Seven studies (15, 32, 45–48,
50) included psycho-pedagogic methods to facilitate the
ability of patients to cope with negative feelings, particularly
associated to body appearance and food assumption. Speranza
et al. (2) provided different treatment approaches, such as
pharmacotherapy (for at least 3 months), psychotherapy (for at
least 6 months), hospitalization (either full or partial), and a
combination of pharmacotherapy with psychotherapy. Ohman
and coworkers (45) also offered once-monthly family sessions, in
the context of 40 weekly sessions of multimodal cognitive
behavioral group therapy (G-CBT) program.
Assessment
All studies but one (2, 15, 32, 45–50) assessed patients with
several questionnaires (either self-report measurers or clinician-
rated interviews) both at baseline and after the intervention.
Beadle et al. (44) tested patients with the TAS only.
Outcomes
In line with the inclusion criteria adopted, alexithymia as
outcome after the intervention was assessed by all studies (2,
15, 32, 44–50). Moreover, four studies (2, 45, 46, 48) evaluated its
possible role as predictor of treatment outcome in the
AN population.
Strengths and Limitations
The current paper provides an up-to-date review of the literature
on alexithymia and treatment outcome in AN. Despite the
clinical relevance of alexithymia, the number of published
studies about its changes after treatment are somewhat limited;
the possibility to compare the results of these studies is hindered
by their heterogeneity and by methodological issues. Besides the
previous review study by Pinna et al. (55), that focused on the
implications of alexithymia as a predictor of treatment outcome
in subjects affected by ED, there are no similar studies on
interventions for alexithymia in anorexic patients, making the
current review useful to the community of researchers in the field
of EDs. Some limitations of this scoping review should be
underscored: first, only two databases (i.e., Medline and
Scopus) were searched to identify relevant articles written in
English language, with potential loss of valuable additional
information. The restriction to published studies could per se
represent a bias in systematic reviews of effectiveness. Despite we
focused on TAS as outcome measure in patients with AN
undergoing any kind of treatment, samples sometimes included
also patients with other EDs, and it was not always possible to
rule out results pertaining only those with a diagnosis of AN.
Last, while we focused on the TAS as the most used tool for the
assessment of alexithymia, and this ensures the homogeneity of
results, this choice obviously lead to the exclusion of all those
studies using other rating scales for alexithymia.February 2020 | Volume 10 | Article 991
Gramaglia et al. Alexithymia, Treatment Outcome in AnorexiaOn the other hand, we adopted restrictive inclusion criteria
and applied the PRISMA methodology for the selection process;
furthermore, we assessed the quality of the studies included in
this review.
Nonetheless, since our aim was to conduct a scoping review of
the literature we did not perform a quantitative data synthesis
nor meta-analysis. This represents a further limitation of the
current study; a meta-analytic approach would certainly
represent an interesting research direction for the future to
allow drawing clear, evidence-based conclusions about the
clinical implications of the findings that have emerged from
our research.CONCLUSIONS
A high rate of individuals with AN achieve incomplete recovery
following treatment. The identification of outcome predictors
such as alexithymia is crucial, as well as that of treatments
specifically targeting these predictors (56–62).
Further studies aimed at a deeper understanding of the actual
impact of alexithymia on the outcome of anorexia are warranted,Frontiers in Psychiatry | www.frontiersin.org 9as well as researches exploring alternative treatment strategies for
alexithymia in EDs.
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